Diabesity? No worries, FKBP11 to the rescue
- PMID: 35793657
- DOI: 10.1016/j.cmet.2022.06.006
Diabesity? No worries, FKBP11 to the rescue
Abstract
Obesity-induced type 2 diabetes, or diabesity, is associated with ER stress, UPR activation, and insulin resistance through poorly understood mechanisms. Herrema et al. (2022) report that the XBP1 target FKBP11 is repressed in the obese mouse liver and that its re-expression activates a protective UPR pathway that restores insulin sensitivity.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests M.K. is a founder of Elgia Pharmaceuticals and received research support from Gossamer Bio, Jansen Pharmaceuticals, and Merck.
Comment on
-
FKBP11 rewires UPR signaling to promote glucose homeostasis in type 2 diabetes and obesity.Cell Metab. 2022 Jul 5;34(7):1004-1022.e8. doi: 10.1016/j.cmet.2022.06.007. Cell Metab. 2022. PMID: 35793654
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases